PUBLISHER: Persistence Market Research | PRODUCT CODE: 1652703

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1652703

Metered Dose Inhalers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

PUBLISHED: January 27, 2025

PAGES: 186 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for metered dose inhalers (MDIs). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global metered dose inhalers market from 2025 to 2032.

Key Insights:

Metered Dose Inhalers Market Size (2025E): USD 30.30 Billion
Projected Market Value (2032F): USD 38.5 Billion
Global Market Growth Rate (CAGR 2025 to 2032):3.5%

Metered Dose Inhalers Market - Report Scope:

Metered dose inhalers (MDIs) are vital in the management of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other lung disorders. These inhalers are designed to deliver a specific dose of medication to the lungs in a consistent and controlled manner. The market includes both conventional MDIs and newer, more advanced inhaler devices, addressing the growing need for efficient and accurate drug delivery systems. Market growth is primarily driven by the increasing prevalence of respiratory diseases, rising pollution levels, and growing awareness about the benefits of inhaler therapy. Advancements in inhaler technologies, such as the introduction of breath-actuated inhalers and the integration of digital health solutions, are expected to further boost market demand.

Market Growth Drivers:

The global metered dose inhalers market is propelled by several key factors, including the rising incidence of asthma and COPD, particularly in aging populations. The increasing use of MDIs in combination with other therapies, such as corticosteroids and bronchodilators, has contributed to their widespread adoption. The growing awareness about the importance of adherence to inhalation therapy and the availability of various device types designed to improve usability further drive market expansion. Additionally, technological advancements in inhaler design, such as the development of dose counters, patient compliance tracking systems, and breath-actuated devices, have made these inhalers more convenient and reliable for users.

Market Restraints:

Despite the positive growth outlook, the metered dose inhalers market faces challenges related to the high cost of advanced inhaler devices and issues surrounding device usability. Patients in low-income regions may face affordability issues, particularly for newer devices with integrated technologies. Moreover, the use of MDIs has been associated with environmental concerns due to the propellants used in traditional inhalers, which contribute to ozone depletion. As regulatory bodies push for greener alternatives, manufacturers will need to adapt to these environmental challenges while ensuring the safety and efficacy of their products.

Market Opportunities:

The metered dose inhalers market presents significant growth opportunities driven by the integration of digital health technologies, such as mobile apps and remote monitoring systems, which allow for improved patient management and better adherence to treatment regimens. Moreover, the increasing focus on personalized medicine and patient-centric approaches to therapy offers new avenues for innovation in inhaler design and functionality. Strategic partnerships with pharmaceutical companies and the growing demand for eco-friendly alternatives are key opportunities for industry players to explore.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the metered dose inhalers market globally?
How are technological advancements reshaping the competitive landscape of the metered dose inhalers market?
What are the key challenges facing the market, and how can companies overcome them?
Who are the leading players in the metered dose inhalers market, and what strategies are they employing to maintain market leadership?
What are the emerging trends and future prospects in the global metered dose inhalers market?

Competitive Intelligence and Business Strategy:

Leading players in the global metered dose inhalers market, including companies such as GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies are heavily investing in R&D to develop new inhaler technologies, such as combination inhalers and eco-friendly MDIs that use alternative propellants. Collaborations with healthcare providers and pharmaceutical companies to offer combination therapies and improve patient adherence are critical strategies to sustain growth in the market.

Key Companies Profiled:

GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Merck & Co.
Novartis AG
Cipla Ltd.
Teva Pharmaceutical Industries Ltd.
Hovione
3M Health Care
Pfizer Inc.

Metered Dose Inhalers Market Research Segmentation

By Type:

Reliever Inhaler
Long-acting bronchodilators Inhaler

By End Use:

Homecare
Hospitals
Clinics

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33723

1. Executive Summary

1.1. Global Metered Dose Inhalers Market Snapshot, 2025 - 2032
1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Type Lifecycle Analysis
2.4. Metered Dose Inhalers Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2019 - 2023
- 3.2.2. Current Market Size Forecast, 2025 - 2032
3.3. Global Metered Dose Inhalers Market Outlook: Type
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2019 - 2023
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
  - 3.3.3.1. Reliever Inhaler
  - 3.3.3.2. Long-Acting Bronchodilators Inhaler
3.4. Market Attractiveness Analysis: Type
3.5. Global Metered Dose Inhalers Market Outlook: End User
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  - 3.5.3.1. Homecare
  - 3.5.3.2. Hospitals
  - 3.5.3.3. Clinics
3.6. Market Attractiveness Analysis: End User

4. Global Metered Dose Inhalers Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
- 5.3.1. By Country
- 5.3.2. By Type
- 5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
- 5.5.1. Reliever Inhaler
- 5.5.2. Long-Acting Bronchodilators Inhaler
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
- 5.6.1. Homecare
- 5.6.2. Hospitals
- 5.6.3. Clinics
5.7. Market Attractiveness Analysis

6. Europe Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
- 6.3.1. By Country
- 6.3.2. By Type
- 6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
- 6.5.1. Reliever Inhaler
- 6.5.2. Long-Acting Bronchodilators Inhaler
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
- 6.6.1. Homecare
- 6.6.2. Hospitals
- 6.6.3. Clinics
6.7. Market Attractiveness Analysis

7. East Asia Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
- 7.3.1. By Country
- 7.3.2. By Type
- 7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
- 7.5.1. Reliever Inhaler
- 7.5.2. Long-Acting Bronchodilators Inhaler
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
- 7.6.1. Homecare
- 7.6.2. Hospitals
- 7.6.3. Clinics
7.7. Market Attractiveness Analysis

8. South Asia & Oceania Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
- 8.3.1. By Country
- 8.3.2. By Type
- 8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
- 8.5.1. Reliever Inhaler
- 8.5.2. Long-Acting Bronchodilators Inhaler
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
- 8.6.1. Homecare
- 8.6.2. Hospitals
- 8.6.3. Clinics
8.7. Market Attractiveness Analysis

9. Latin America Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
- 9.3.1. By Country
- 9.3.2. By Type
- 9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
- 9.5.1. Reliever Inhaler
- 9.5.2. Long-Acting Bronchodilators Inhaler
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
- 9.6.1. Homecare
- 9.6.2. Hospitals
- 9.6.3. Clinics
9.7. Market Attractiveness Analysis

10. Middle East & Africa Metered Dose Inhalers Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
- 10.3.1. By Country
- 10.3.2. By Type
- 10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2025 - 2032
- 10.5.1. Reliever Inhaler
- 10.5.2. Long-Acting Bronchodilators Inhaler
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
- 10.6.1. Homecare
- 10.6.2. Hospitals
- 10.6.3. Clinics
10.7. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2024
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Type Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Cipla Inc.
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Type
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Presspart Manufacturing Ltd
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Type
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Midascare Pharmaceuticals Pvt. Ltd
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Type
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Beximco Pharma Ltd.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Type
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. GlaxoSmithKline Pharmaceuticals Ltd.
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Type
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. 3M Pharmaceuticals Pty Ltd.
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Type
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Biocare Manufacturing Sdn Bhd.
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Type
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Anomatic Innovation & Design Center & Manufacturing
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Type
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Aristo Pharma Ltd.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Type
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ